Samuel Lunenfeld Research Institute Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2013
NCT01755572
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Samuel Lunenfeld Research Institute | Samuel Lunenfeld Research Institute, TGRI